Ivana Sullivan
Clinical Research Medical Director Amgen Inc.
Ivana Sullivan, MD, PhD, is a medical oncologist specializing in thoracic malignancies and a Clinical Research Medical Director at Amgen, where she contributes to the global development of targeted therapies for lung cancer. She received her medical degree from the National University of Rosario (Argentina), completed her medical oncology training at Hospital de la Santa Creu i Sant Pau (Barcelona), and earned her PhD from the Autonomous University of Barcelona (UAB). She also conducted translational research at Gustave Roussy Cancer Campus in France. Dr. Sullivan has presented her work at ASCO, ESMO, and WCLC and has authored multiple peer-reviewed publications in thoracic oncology.
Seminars
Tuesday 8th September 2026
Advancing First Line Care for KRAS G12C positive & PD L1 negative NSCLC: Optimizing Targeted Therapy + Chemotherapy for a High-Unmet- Need Population
2:30 pm
- Highlighting the distinct clinical profile and poor real world outcomes of KRAS G12C +ve / PD L1 -ve NSCLC, underscoring why this population represents a critical unmet need in first line treatment.
- Demonstrating how a cleaner, biomarker defined trial design and a safer chemo + targeted therapy approach may avoid early immunotherapy related toxicities while preserving future treatment options
- Exploring the role of translational research, including proteomics, transcriptomics, and longitudinal blood sampling, in understanding treatment response, resistance, and sequencing strategies across the patient journey
